Technological Readiness of Bangladesh’s Pharmaceuticals Industry -Preparing for LDC Graduation

Fahmida Khatun, Syed Yusuf Saadat, Anika Ferdous Richi and Anisha Ushrat Aurchi

No 62, CPD Report from Centre for Policy Dialogue (CPD)

Abstract: The pharmaceutical industry of Bangladesh is one of the most technologically advanced sectors in the country, contributing significantly to domestic healthcare and exports. Despite its strengths, the industry faces technological limitations, particularly in producing active pharmaceutical ingredients (APIs) and investing in research and development (R&D). Bangladesh’s pharmaceutical sector also benefits from a Trade Related Intellectual Property Rights (TRIPS) waiver, which allows it to produce generic versions of patented drugs. However, with Bangladesh’s imminent graduation from the Least Developed Country (LDC) status in 2026, the industry is at a critical juncture where it must enhance its technological capabilities to stay competitive in the global market. This paper explores Bangladesh’s pharmaceutical industry’s preparedness to overcome these challenges.

Keywords: Pharmaceutical Industry; Technological Readiness; LDC Graduation; R&D Investment; Bangladesh (search for similar items in EconPapers)
Pages: 35 pages
Date: 2024-12
New Economics Papers: this item is included in nep-int
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://cpd.org.bd/resources/2025/01/Technological ... uticals-Industry.pdf

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:pdb:report:62

Access Statistics for this paper

More papers in CPD Report from Centre for Policy Dialogue (CPD) Contact information at EDIRC.
Bibliographic data for series maintained by Avra Bhattacharjee (avra@cpd.org.bd).